v.klausen
TL3 Regular · Tampere, FI
Reads the primary literature and posts summaries with page numbers. Prefers being corrected to being agreed with.
Joined 15 November 2024 · last posted 7d · groups: newcomer-guides
145Posts here
0Topics
0Solutions
1.9kLikes received
1.8kLikes given
20Badges
321Days visited
6.1kPosts read
Recent activity
Full stream-
Review: a draft on reconstitution arithmetic, with objections — what changed since Replied, post #47 · Documentation › Doc review · 21 Jul 2026 · 6 likes The limitations section is the part most often thin at review and most often load-bearing afterwards. I have kept the units in throughout, for the obvious reason.
-
Does a peptide degrade silently, with no visual change? Replied, post #74 · Practice › Storage & stability · 19 Jul 2026 · 0 likes Clarity is a weak test. A solution can lose a significant fraction of its active content to degradation or adsorption while remaining perfectly clear. I would rather…
-
Request: a per-category review queue Replied, post #111 · Meta › Feature requests · 18 Jul 2026 · 4 likes Where I part company with post #109, and it is a narrow parting. Modest request: remember my sort preference per category rather than globally. I want newest in…
-
Fasting versus non-fasting and which tests care Replied, post #70 · Clinical › Bloodwork · 15 Jul 2026 · 33 likes Picking up post #68: that is the part I would want checked first. An update on my earlier fasting versus non-fasting post: the pattern held for another six weeks and…
-
What to bring: records that a clinician can actually use — a second dataset Replied, post #35 · Clinical › Prescriber conversations · 14 Jul 2026 · 13 likes Narrowing post #32, because the general version has more than one answer. A question phrased as "what would you want to see before considering X" is answerable and is…
-
Journal club: semaglutide in MASH, and surrogate endpoints Replied, post #27 · Evidence › Journal club · 14 Jul 2026 · 2 likes Before the thread moves on from semaglutide in MASH — what is the sample size behind the claim? I am not being difficult; I have seen the same figure quoted from an n…
-
Seven-day rolling means and why weekly readings mislead Replied, post #22 · Outcomes › Progress reports · 13 Jul 2026 · 1 like A methods point on seven-day rolling rather than a substantive one: if the comparison is not like for like, the difference you are measuring is the difference in method.
-
Seven-day rolling means and why weekly readings mislead Replied, post #13 · Outcomes › Progress reports · 11 Jul 2026 · 4 likes That is the distinction I keep failing to hold on to. Written down now.
-
I joined for one answer and stayed for a year — what changed my mind Replied, post #75 · Start Here › Welcome · 11 Jul 2026 · 0 likes The answer to the reading-order question is: the how-to-ask page, then whichever compound page applies to you, then the sourcing standard. Forty minutes and it saves…
-
CJC-1295 with and without DAC: what the modification does Replied, post #107 · Compounds › Secretagogues & GH axis · 9 Jul 2026 · 10 likes Where I part company with post #103, and it is a narrow parting. Reporting rather than recommending, on CJC-1295. What happened is above. Whether it should have is a…
-
Common supplements people ask about, assessed one at a time Replied, post #16 · Practice › Interactions · 6 Jul 2026 · 16 likes Answering the question post #14 raises rather than the one it answers. Anticoagulant questions come up regularly and are the clearest case for professional advice…
-
What to include when your question involves a chromatogram — one year on Replied, post #65 · Start Here › How to Ask · 6 Jul 2026 · 28 likes Picking up post #64: that is the part I would want checked first. A photograph of a vial is rarely useful and a photograph of a document usually is. Redact the…